☰

John D. Minna

Affiliations: 
Sammons Cancer Center University of Texas Southwestern Medical Center at Dallas, Dallas, TX, United States 
Google:
"John Minna"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Alex Augustyn grad student UT Southwestern (MPROTree)
Sanjay Awasthi post-doc 1990-1991 University of Texas Southwestern Medical Center at Dallas

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cai L, Gao Y, DeBerardinis R, et al. (2024) A Lung Cancer Mouse Model Database. Biorxiv : the Preprint Server For Biology
Nabet BY, Hamidi H, Lee MC, et al. (2024) Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade. Cancer Cell
Eglenen-Polat B, Kowash RR, Huang HC, et al. (2024) A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer. Nature Communications. 15: 672
Kim C, Wang XD, Liu Z, et al. (2024) Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors. Science Advances. 10: eadh2579
Chen H, Drapkin BJ, Minna JD. (2024) Proteomics: A new dimension to decode small cell lung cancer. Cell. 187: 14-16
Ng J, Cai L, Girard L, et al. (2024) Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. OF1-OF13
Sunaga N, Kaira K, Shimizu K, et al. (2023) The oncogenic role of LGR6 overexpression induced by aberrant Wnt/β-catenin signaling in lung cancer. Thoracic Cancer
Zhu M, Kim J, Deng Q, et al. (2023) Loss of p53 and mutational heterogeneity drives immune resistance in an autochthonous mouse lung cancer model with high tumor mutational burden. Cancer Cell
Malchers F, Nogova L, van Attekum MH, et al. (2023) Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer. The Journal of Clinical Investigation
Kawabe N, Matsuoka K, Komeda K, et al. (2023) Silencing of induces epithelial‑to‑mesenchymal transition in lung cancer cell lines with different effects on proliferation and clonogenic growth. Oncology Letters. 26: 391
See more...